Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 1Phase 1/2 1

Status

Recruiting 3Active not recruiting 3

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 6Sarcoma 1Lymphoid 1

Conditions

Breast Neoplasms 221Carcinoma, Non-Small-Cell Lung 218Prostatic Neoplasms 150Multiple Myeloma 140Neoplasms 129Colorectal Neoplasms 117Leukemia, Myeloid, Acute 106Lung Neoplasms 102Neoplasm Metastasis 95Squamous Cell Carcinoma of Head and Neck 91Carcinoma, Hepatocellular 84Lymphoma 78Melanoma 77Triple Negative Breast Neoplasms 71Pancreatic Neoplasms 71Ovarian Neoplasms 66Sarcoma 64Lymphoma, Large B-Cell, Diffuse 61Carcinoma, Renal Cell 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Head and Neck Neoplasms 57Recurrence 56Brain Neoplasms 56Lymphoma, Non-Hodgkin 53Hematologic Neoplasms 52Stomach Neoplasms 51Leukemia, Lymphocytic, Chronic, B-Cell 51Endometrial Neoplasms 50Small Cell Lung Carcinoma 48Rectal Neoplasms 46

Interventions

Radiotherapy 2Proton Therapy 2tovorafenib 1tocilizumab 1binimetinib 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Methionine 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Craniopharyngioma × 90 days × Clear all
NCT01419067 2026-04-29

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
112 enrolled
CNS

Craniopharyngioma

NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02792582 2026-04-23

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
160 enrolled
CNS

Brain Neoplasms, Craniopharyngioma

NCT05233397 2026-04-23

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital

Phase 2 Recruiting
30 enrolled
CNS

Craniopharyngioma

NCT05465174 2026-04-23

PNOC029

University of California, San Francisco

Phase 2 Recruiting
57 enrolled
CNS

Craniopharyngioma

NCT05286788 2026-04-08

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital

Phase 2 Recruiting
38 enrolled
CNS

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡